iBio
Using artificial intelligence to efficiently and consistently delivers antibody candidates against difficult targets.
Launch date
Employees
Market cap
€15.1m
Enterprise valuation
€26m (Public information from Sep 2024)
Share price
$1.9 IBIO
Newark New Jersey (HQ)
Authorizing premium user...